NCT07036042View on ClinicalTrials.gov

Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Autoimmune Encephalitis

Trial Locations (1)

510515

Nanfang hospital, Guangzhou

All Listed Sponsors

lead

Nanfang Hospital, Southern Medical University

OTHER